REEF: Improving medications for autoimmune disease

Coral is conducting a large NIH-sponsored study comparing and predicting the relative effectiveness of different medications for autoimmune patients. Patients with Inflammatory Bowel Disease (IBD) who have been diagnosed with either Ulcerative Colitis (UC) or Crohn's Disease (CD) and are undergoing treatment are eligible to participate. Patients with Rheumatoid Arthritis (RA) and Psoriasis (Ps) are also being recruited. In order to participate in the study patients will agree to:

  1. allow 1 tube of blood to be collected by an in-home phlebotomist
  2. provide permission for us to obtain medical records from your provider
  3. complete an electronic questionnaire about your current health situation to be sent to you a few months after enrollment
Patients who complete all requirements of the study are eligible to recieve up to $150 in gift cards.

See link below for more information:

NCT04995783: ClinicalTrials.gov

Submit your email and/or phone number to enroll in the REEF study

* indicates required